Table 2.
Number of trials remaining after artifact rejection for auditory and somatosensory evoked response tasks.
| Measure | Study Group | F | Partial η2 | ||
|---|---|---|---|---|---|
| ASD M ± SD [Range] | SPD M ± SD [Range] | TDC M ± SD [Range] | |||
| AUDITORY EVOKED FIELDS (500 TRIALS PRESENTED) | |||||
| Artifact free trials | 446.67 ± 26.52 [349–475] | 438.08 ± 43.23 [360–490] | 461.44 ± 31.47 [377–492] | 1.94 | 0.08 |
| SOMATOSENSORY EVOKED FIELDS (500 TRIALS PRESENTED) | |||||
| Artifact free trials | 459.83 ± 19.31 [406–489] | 452.92 ± 21.16 [416–488] | 475.78 ± 17.11ab[438–496] | 6.07* | 0.21 |
*
p = 0.005.
a
Significantly different from ASD group at p < 0.05.
b
Significantly different from SPD group at p < 0.01.